Direct reprogramming for cardiac regeneration: From dream to reality

Circulation Research

Volumn 110, Issue 11, 2012, Pages 1392-1394

  Bruneau, Benoit G ^a,b  

^a GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 1; MICRORNA 133; MICRORNA 208; MICRORNA 499; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CELL TRANSFORMATION; CELL TYPE; DIRECT REPROGRAMMING; FIBROBLAST; HEART INFARCTION; HEART MUSCLE CELL; HEART REGENERATION; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; TISSUE REGENERATION; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; CELL TRANSDIFFERENTIATION; FIBROBLASTS; MALE; MICRORNAS; MYOCYTES, CARDIAC;

EID: 84861651448     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.112.270637     Document Type: Review

References (18)

1. Qian L, Huang Y, Spencer CI, Foley A, Vedantham V, Liu L, Conway SJ, Fu JD, Srivastava D. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. [epub April 18, 2012]. Nature. 2012. doi: 10.1038/nature11044.
2. Jayawardena TM, Egemnazarov B, Finch EA, Zhang L, Payne JA, Pandya K, Zhang Z, Rosenberg P, Mirotsou M, Dzau VJ. MicroRNAmediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes. Circ Res. 2012;110;1465-1473.
3. Alexander JM, Bruneau BG. Lessons for cardiac regeneration and repair through development. Trends Mol Med. 2010;16:426-434.
4. Laflamme MA, Murry CE. Heart regeneration. Nature. 2011;473: 326-335.
5. Williams AR, Hare JM. Mesenchymal stem cells: Biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circulation Research. 2011;109:923-940.
6. Bolli R, Chugh AR, D'Amario D, et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (scipio): Initial results of a randomised phase 1 trial. Lancet. 2011;378:1847-1857.
7. Yamanaka S, Blau HM. Nuclear reprogramming to a pluripotent state by three approaches. Nature. 2010;465:704-712.
8. Graf T, Enver T. Forcing cells to change lineages. Nature. 2009;462: 587-594.
9. Cherry AB, Daley GQ. Reprogramming cellular identity for regenerative medicine. Cell. 2012;148:1110-1122.
10. Efe JA, Hilcove S, Kim J, Zhou H, Ouyang K, Wang G, Chen J, Ding S. Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy. Nat Cell Biol. 2011;13:215-222.
11. Ieda M, Fu JD, Delgado-Olguin P, Vedantham V, Hayashi Y, Bruneau BG, Srivastava D. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell. 2010;142:375-386.
12. Ivey KN, Srivastava D. Micrornas as regulators of differentiation and cell fate decisions. Cell Stem Cell. 2010;7:36-41.
13. Small EM, Olson EN. Pervasive roles of micrornas in cardiovascular biology. Nature. 2011;469:336-342.
14. Xu Y, Shi Y, Ding S. A chemical approach to stem-cell biology and regenerative medicine. Nature. 2008;453:338-344.
15. Bock-Marquette I, Saxena A, White MD, Dimaio JM, Srivastava D. Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature. 2004;432:466-472.
16. Onder TT, Kara N, Cherry A, Sinha AU, Zhu N, Bernt KM, Cahan P, Mancarci OB, Unternaehrer J, Gupta PB, Lander ES, Armstrong SA, Daley GQ. Chromatin-modifying enzymes as modulators of reprogramming. Nature. 2012;483:598-602.
17. Lin T, Ambasudhan R, Yuan X, Li W, Hilcove S, Abujarour R, Lin X, Hahm HS, Hao E, Hayek A, Ding S. A chemical platform for improved induction of human ipscs. Nat Methods. 2009;6:805-808.
18. Zhu S, Li W, Zhou H, Wei W, Ambasudhan R, Lin T, Kim J, Zhang K, Ding S. Reprogramming of human primary somatic cells by oct4 and chemical compounds. Cell Stem Cell. 2010;7:651-655.